Earl-Slater A
Keele University, UK.
Health Serv J. 1997 Nov 6;107(5578):22-3.
There is no evidence that the UK's pharmaceutical price regulation scheme is working. Arguments for abolishing it are that it is seriously flawed and inappropriate to today's health service, and that there are better alternatives. A regional drugs committee which makes evidence-based recommendations to GPs, could be a suitable alternative. The government should look to the experience of other countries and consult with healthcare professionals and the public before making any changes.
没有证据表明英国的药品价格监管计划正在发挥作用。主张废除该计划的理由是,它存在严重缺陷,不适用于当今的医疗服务,而且有更好的替代方案。一个向全科医生提供循证建议的地区药品委员会可能是一个合适的替代方案。政府在做出任何改变之前,应该借鉴其他国家的经验,并咨询医疗保健专业人员和公众的意见。